NASDAQ: MEIPMei Pharma Inc Stock Ownership - Who owns Mei Pharma?
Insider buying vs selling
Have Mei Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Steven D. Wood | Director | 2024-05-17 | 3,100 | $3.17 | $9.83kBuy |
| James P. Flynn | Director | 2024-05-16 | 7,900 | $3.16 | $24.98kBuy |
MEIP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MEIP insiders and whales buy or sell their stock.
MEIP Shareholders
What type of owners hold Mei Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vivo Ventures VII LLC | 110.86% | 7,386,473 | $14.52M | Insider |
| Josiah T. Austin | 57.51% | 3,832,081 | $7.53M | Insider |
| Anson Funds Management LP | 16.41% | 1,093,188 | $2.15M | Insider |
| Anson Funds Management LP | 16.41% | 1,093,184 | $2.15M | Institution |
| Funicular Funds LP | 14.08% | 937,840 | $1.84M | Insider |
| Cable Car Capital LP | 9.18% | 611,440 | $1.20M | Institution |
| Vivo Ventures V LLC | 6.44% | 429,136 | $843.68k | Insider |
| Daniel P. Phd Gold | 6.26% | 417,312 | $820.44k | Insider |
| Vanguard Group Inc | 5.79% | 385,728 | $758.34k | Institution |
| Renaissance Technologies LLC | 2.03% | 134,946 | $265.30k | Institution |
MEIP vs Biotech Stocks
Mei Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.